federal_register: 2023-00390
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-00390 | Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal; Correction | Notice | The Food and Drug Administration is correcting a notice entitled "Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal" that appeared in the Federal Register of December 13, 2022. The document announced the renewal of the Cardiovascular and Renal Drugs Advisory Committee. The document was published with the incorrect docket number. This document corrects that error. | 2023-01-11 | 2023 | 1 | https://www.federalregister.gov/documents/2023/01/11/2023-00390/advisory-committee-cardiovascular-and-renal-drugs-advisory-committee-renewal-correction | https://www.govinfo.gov/content/pkg/FR-2023-01-11/pdf/2023-00390.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration is correcting a notice entitled "Advisory Committee; Cardiovascular and Renal Drugs Advisory Committee; Renewal" that appeared in the Federal Register of December 13, 2022. The document announced the renewal of the... |